Literature DB >> 10667001

Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.

A T Soliman1, M M elZalabany, Y Mazloum, S M Bedair, M S Ragab, A D Rogol, B M Ansari.   

Abstract

Growth retardation in children with thalassaemia major is multifactorial. We studied the growth hormone (GH) response to provocation by clonidine and glucagon, measured the circulating concentrations of insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-3 (IGFBP3), and ferritin, and evaluated the spontaneous nocturnal (12 h) GH secretion in prepubertal patients with thalassaemia and age-matched children with constitutional short stature (CSS) (height SDS < -2, but normal GH response to provocation). The anatomy of the hypothalamic pituitary area was studied in patients with abnormal GH secretion using MRI scanning. Children with thalassaemia had significantly lower peak GH response to provocation by clonidine and glucagon (8.8 +/- 2.3 micrograms/l and 8.2 +/- 3.1 micrograms/l respectively) than did controls (17.6 +/- 2.7 micrograms/l and 15.7 +/- 3.7 micrograms/l respectively). They had significantly decreased circulating concentrations of IGF-I and IGFBP3 (68.5 +/- 19 ng/ml and 1.22 +/- 0.27 mg/l respectively) compared to controls (153 +/- 42 ng/ml and 2.16 +/- 0.37 mg/l respectively). Seven of the thalassaemic children had a GH peak response of < 7 micrograms/l after provocation. Those with a normal GH response after provocation also had significantly lower IGF-I and IGFBP3 concentrations than controls. Analysis of their spontaneous nocturnal GH secretion revealed lower mean (2.9 +/- 1.77 micrograms/l) and integrated (2.53 +/- 1.6 micrograms/l) concentrations compared to controls (4.9 +/- 0.29 micrograms/l and 5.6 +/- 0.52 micrograms/l respectively). Five of them had mean nocturnal GH concentration < 2 micrograms/l and four had maximum nocturnal peak below 10 micrograms/l. These data denoted defective spontaneous GH secretion in some of these patients. MRI studies revealed complete empty sella (n = 2), marked diminution of the pituitary size (n = 4), thinning of the pituitary stalk (n = 3) with its posterior displacement (n = 2), and evidence of iron deposition in the pituitary gland and midbrain (n = 7) in those patients with defective GH secretion (n = 9). Serum ferritin concentration was correlated significantly with the circulating IGF-I (r = -0.47, p < 0.01) and IGFBP3 (r = -0.43, p < 0.01) concentrations. These data prove a high prevalence of defective GH secretion in thalassaemic children associated with structural abnormality of their pituitary gland.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10667001     DOI: 10.1093/tropej/45.6.327

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  12 in total

Review 1.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

2.  Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.

Authors:  Maria Ebbesen; Sarah Weischendorff; Katrine Kielsen; Marte Kammersgaard; Anders Juul; Klaus Gottlob Müller
Journal:  Bone Marrow Transplant       Date:  2020-11-20       Impact factor: 5.483

3.  Thalassaemia and aberrations of growth and puberty.

Authors:  Andreas Kyriakou; Nicos Skordis
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-27       Impact factor: 2.576

4.  Screening of growth hormone deficiency in short thalassaemic patients and effect of L-carnitine treatment.

Authors:  Amal El Beshlawy; Soha M Abd El Dayem; Fatma El Mougy; Esmat Abd El Gafar; Hend Samir
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

Review 5.  Insulin-like growth factor- I and factors affecting it in thalassemia major.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Rania Elalaily; Mohamed Yassin
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

6.  Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Giancarlo Candini; Mohamed Yassin; Giuseppe Raiola; Maria Concetta Galati; Rania Elalaily; Heba Elsedfy; Nicos Skordis; Piernicola Garofalo; Salvatore Anastasi; Saveria Campisi; Mehran Karimi; Christos Kattamis; Duran Canatan; Yurdanur Kilinc; Praveen Sobti; Bernadette Fiscina; Mohamed El Kholy
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

7.  Anemia and growth.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2014-11

Review 8.  Growth and Growth hormone - Insulin Like Growth Factor -I (GH-IGF-I) Axis in Chronic Anemias.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin; Ashraf Adel
Journal:  Acta Biomed       Date:  2017-04-28

9.  Hematological and biochemical status of Beta-thalassemia major patients in Bangladesh: A comparative analysis.

Authors:  Md Fazlul Karim; Md Ismail; Akm Mahbub Hasan; Hossain Uddin Shekhar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-01-01

10.  Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Maria Ebbesen; Christian Enevold; Anders Juul; Carsten Heilmann; Henrik Sengeløv; Klaus Müller
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.